UnitedHealth Group (NYSE:UNH) Given New $427.00 Price Target at Robert W. Baird

Key Points

• Robert W. Baird lowered UnitedHealth’s price target to $427 from $453 and maintained a “neutral” rating, implying about 12.8% upside from the previous close. Despite the cut, analysts overall hold a “Moderate Buy” consensus with a $461.69 average target.
• UnitedHealth reported quarterly adjusted EPS of $4.69, beating the $4.14 consensus, while revenue reached $112.7 billion versus $111.31 billion expected. Management raised its 2026 adjusted EPS outlook to at least $20.50.
• Investors remain focused on Medicare-related pressures and essentially flat year-over-year revenue, suggesting the recovery is being driven mainly by improved margins and cost controls rather than broad top-line growth.

UnitedHealth Group (NYSE:UNH - Get Free Report) had its price objective lowered by investment analysts at Robert W. Baird from $453.00 to $427.00 in a report released on Wednesday, Benzinga reports. The firm presently has a "neutral" rating on the healthcare conglomerate's stock. Robert W. Baird's price target indicates a potential upside of 12.79% from the stock's previous close.

Other analysts have also recently issued reports about the company. KeyCorp boosted their price objective on UnitedHealth Group from $400.00 to $475.00 and gave the company an "overweight" rating in a research report on Tuesday, July 14th. Royal Bank Of Canada lifted their price target on shares of UnitedHealth Group from $463.00 to $478.00 and gave the stock an "outperform" rating in a research note on Friday, July 17th. Truist Financial boosted their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the company a "buy" rating in a report on Tuesday, July 14th. Erste Group Bank cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Thursday, August 27th. Finally, Mizuho raised their price objective on shares of UnitedHealth Group from $470.00 to $493.00 and gave the stock an "outperform" rating in a report on Monday, July 20th. Twenty analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $461.69.

UnitedHealth Group Trading Up 0.0%

Shares of UNH stock opened at $378.59 on Wednesday. The firm has a market capitalization of $339.82 billion, a P/E ratio of 24.36, a price-to-earnings-growth ratio of 1.42 and a beta of 0.60. UnitedHealth Group has a 1 year low of $255.96 and a 1 year high of $461.62. The firm's fifty day simple moving average is $387.44 and its 200 day simple moving average is $382.57. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business had revenue of $112.70 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same quarter in the prior year, the business earned $2.59 earnings per share. The firm's revenue for the quarter was down .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, sell-side analysts predict that UnitedHealth Group will post 19.85 EPS for the current year.

Insider Buying and Selling

In other news, CEO Patrick Conway sold 1,169 shares of the stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.19% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. lifted its position in UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after buying an additional 3,395,530 shares in the last quarter. State Street Corp increased its holdings in shares of UnitedHealth Group by 0.7% in the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate's stock worth $18,966,555,000 after acquiring an additional 301,081 shares during the period. Bank of America Corp DE increased its position in UnitedHealth Group by 21.8% in the 1st quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate's stock valued at $3,169,606,000 after acquiring an additional 2,097,859 shares during the period. Bank of New York Mellon Corp raised its holdings in UnitedHealth Group by 6.1% during the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate's stock worth $4,449,317,000 after purchasing an additional 616,723 shares in the last quarter. Finally, Wellington Management Group LLP lifted its holdings in UnitedHealth Group by 5.8% in the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate's stock valued at $4,436,923,000 after acquiring an additional 583,536 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth reported adjusted earnings of $4.69 per share, well above the approximately $4.14 analyst consensus, while revenue of $112.7 billion also exceeded estimates. Operating earnings rose 52% to $6.6 billion, supported by tighter medical-cost controls and improved execution. UnitedHealth Group tops estimates, hikes profit outlook as insurer manages high medical costs
• Positive Sentiment: Management raised its 2026 adjusted EPS outlook to at least $20.50, above the roughly $19.86 consensus estimate. The company also indicated that current analyst expectations for 2027 may be conservative, reinforcing the view that its turnaround is progressing. UnitedHealth Says Wall Street May Be Underestimating Its 2027 Earnings Potential
• Positive Sentiment: The medical care ratio improved to 88.4%, while artificial-intelligence tools reportedly reduced clinical-review times and administrative friction. Management also expects Medicaid margins to bottom in 2026 and improve thereafter. UnitedHealth Group Earnings Call Highlights Growth and AI
• Neutral Sentiment: Despite the earnings beat, revenue was essentially flat year over year and Optum Health revenue slipped, suggesting that the recovery is being driven more by margins and cost discipline than by broad-based top-line expansion.
• Negative Sentiment: Investors remain concerned about UnitedHealth’s Medicare strategy, including the impact of exiting or reducing exposure to less-profitable Medicare business. Those concerns cloud the otherwise strong quarter and explain why the stock reversed its early advance. UnitedHealth Group Drops 5.4% as Medicare Exit Clouds Q3 Beat

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.